Literature DB >> 10902765

Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.

P K Petrow1, K M Hummel, J Schedel, J K Franz, C L Klein, U Müller-Ladner, J Kriegsmann, P L Chang, C W Prince, R E Gay, S Gay.   

Abstract

OBJECTIVE: Osteopontin (OPN) is an extracellular matrix protein that has been implicated in the interactions between tumor cells and host matrix, including those involved in invasion and spread of tumor cells. Because joint destruction in rheumatoid arthritis (RA) is mediated by the invasive growth of synovial tissue through its attachment to cartilage, we examined the expression of OPN in the synovia of patients with RA and the effect of OPN on the production of collagenase 1 in rheumatoid synovial fibroblasts and articular chondrocytes.
METHODS: The expression of OPN messenger RNA (mRNA) and protein in synovia from 10 RA patients was examined by in situ hybridization and immunohistochemistry. Synovial fibroblasts from RA patients and articular chondrocytes from patients without joint disease were cultured in the presence of various concentrations of OPN, and levels of collagenase 1 in the culture supernatants were measured by enzyme-linked immunosorbent assay.
RESULTS: The expression of OPN mRNA and protein was observed in 9 of 10 specimens obtained from patients with RA. OPN was expressed in the synovial lining and sublining layer and at the interface of cartilage and invading synovium. Double labeling revealed that the majority of OPN-expressing cells were positive for the fibroblast-specific enzyme prolyl 4-hydroxylase and negative for the macrophage marker CD68, while only a few, single OPN-expressing cells were positive for CD68 at sites of synovial invasion into cartilage. OPN staining was not observed in lymphocytic infiltrates or leukocyte common antigen (CD45)-positive cells. Three of 3 cultures of human articular chondrocytes secreted detectable basal amounts of collagenase, with a dose-dependent increase upon OPN stimulation, while synovial fibroblast cultures produced much lower levels of collagenase, with only 2 of 4 fibroblast cultures responding in a dose-dependent manner.
CONCLUSION: These findings suggest that OPN produced by synovial fibroblasts in the synovial lining layer and at sites of cartilage invasion not only mediates attachment of these cells to cartilage, but also contributes to matrix degradation in RA by stimulating the secretion of collagenase 1 in articular chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10902765     DOI: 10.1002/1529-0131(200007)43:7<1597::AID-ANR25>3.0.CO;2-0

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis.

Authors:  R Marciano; F Giacopelli; M T Divizia; M Gattorno; E Felici; A Pistorio; A Martini; R Ravazzolo; P Picco
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

Review 3.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

4.  Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.

Authors:  Guangwu Xu; Hong Nie; Ningli Li; Wenxin Zheng; Dongqing Zhang; Guozhang Feng; Liqing Ni; Rong Xu; Jian Hong; Jingwu Z Zhang
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

5.  Roles of microRNA-539 and osteopontin in rheumatoid arthritis.

Authors:  Yan Liu; Kai Qian; Chunmei Li; Yi Ma; Xingguo Chen
Journal:  Exp Ther Med       Date:  2017-12-21       Impact factor: 2.447

6.  Effect of osteopontin on the mRNA expression of ADAMTS4 and ADAMTS5 in chondrocytes from patients with knee osteoarthritis.

Authors:  Shu-Guang Gao; Chao Zeng; Yang Song; Jian Tian; Chao Cheng; Tuo Yang; Hui Li; Fang-Jie Zhang; Guang-Hua Lei
Journal:  Exp Ther Med       Date:  2015-02-24       Impact factor: 2.447

Review 7.  Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases.

Authors:  R L Wilder
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

8.  Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.

Authors:  Nobuchika Yamamoto; Fumihiko Sakai; Shigeyuki Kon; Junko Morimoto; Chiemi Kimura; Harumi Yamazaki; Ikuko Okazaki; Nobuo Seki; Takashi Fujii; Toshimitsu Uede
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 9.  Osteopontin: a bridge between bone and the immune system.

Authors:  Ellen M Gravallese
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

10.  Molecular basis of recognition of human osteopontin by 23C3, a potential therapeutic antibody for treatment of rheumatoid arthritis.

Authors:  Jiamu Du; Sheng Hou; Chen Zhong; Zheng Lai; Hui Yang; Jianxin Dai; Dapeng Zhang; Hao Wang; Yajun Guo; Jianping Ding
Journal:  J Mol Biol       Date:  2008-07-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.